November 15, 2013 |
LIKELY OSCAR nominee Matthew McConaughey devours another plum role in "Dallas Buyers Club," playing a homophobic, straight rodeo hand who gets HIV back in the 1980s. The man's bigotry erodes, of course, when he enters the orbit of AIDS patients, most of whom are gay, but the movie is less about empathy than defiance - defined by the way McConaughey embodies his character's Texas-sized streak of independence. When doctors (Jennifer Garner, Dennis O'Hare) tell him he has a month to live, he yanks the tubes from his arms and walks bare-ass out of the emergency room.
September 25, 2012
Jerome P. Horwitz, 93, a scientific researcher who created AZT in 1964 in the hope that it would cure cancer but who entered the medical pantheon decades later when AZT became the first successful drug treatment for people with AIDS, died on Sept. 6 in Bloomfield Township, Mich. His wife, Sharon Horwitz, confirmed his death, which had not been widely reported until last week. Dr. Horwitz never achieved much fame and did not earn a penny for making the AZT compound. The riches - billions of dollars eventually - went to the drug company that tested it, patented it and, in 1986, won federal approval for it as the first treatment proven to prolong AIDS patients' lives.
September 13, 2010 |
Last spring, Lafayette Sanders got a call from a friend who was concerned about his reputation. The word on the street, she said, was that he and his girlfriend had HIV, the virus that causes AIDS. It was true about Sanders, and he told her so because his friend was so supportive. But Sanders, then 23, also decided that he needed to tell all his friends that he had been HIV-positive - for his entire life. Sanders, of West Philadelphia, belongs to a rare group; he was born HIV-positive when he was perinatally infected via his mother either during pregnancy and delivery or breastfeeding.
June 26, 2001
As delegates gather this week at the United Nations to work on a global strategy to combat AIDS, some - but not all - of the world's nations are emerging from the "denial stage. " So far, the Human Immunodeficiency Virus has infected 58 million people - 22 million have already died. Seventy percent of the infected live in Africa. And as long as the infection rate remains high in one country, the danger remains high for all countries, including the United States. A critical next step is to reject the false choice that has been set up by some nations and pharmaceutical companies between prevention efforts and treatment of those already infected.
April 9, 2001 |
When Barbara Kenyon established rape victims' centers here last year, she didn't intend to create a political battle over AIDS, medicine and race. That's just how it turned out. Government health officials have moved to close the rape centers because they were providing rape victims with free medicine to reduce the risk of AIDS. The impasse in Nelspruit, a semi-tropical region of citrus and sugar cane plantations on the border of Kruger National Park, is a microcosm of the paralysis that has overwhelmed the government's response to the AIDS pandemic.
March 6, 2001 |
At his Center City office, Jean-Pierre Garnier, chief executive officer of GlaxoSmithKline, the world's largest manufacturer of AIDS medicines, has an enormous item on his to-do list: Figure out how to save more than 25 million people infected with the AIDS virus in Africa. And how to do it without choking off his company's ability to pay for research to help millions more throughout the world awaiting cures for cancer, heart disease and diabetes. "I think about it every day," Garnier said.
November 30, 2000 |
On the eve of World AIDS Day, the latest news about the global epidemic runs the gamut from good to horrific - and even the so-called good news is bad if you scratch the surface. First, the good news: In wealthy countries, including the United States, the rate of HIV infection has not increased, reports the "AIDS Epidemic Update" published by the United Nations AIDS agency and the World Health Organization. But neither has it fallen. The number of newly infected people is about 45,000 in North America and 30,000 in Western Europe, a rate of infection no lower than last year's.
July 10, 2000 |
President Thabo Mbeki of South Africa has so exasperated AIDS researchers that some have decided not to attend the international AIDS conference in his country. First, he said AZT, which has safely helped prolong the lives of hundreds of thousands of people with HIV, might be too toxic for his people. Then he announced that he was willing to entertain the ridiculous views of the marginalized scientists who say HIV does not cause AIDS. But when Mbeki spoke to an audience in San Francisco a few months ago, his iconoclasm began to make sense.
June 3, 2000
South African President Thabo Mbeki is beginning to distance himself from the discredited idea that the HIV virus does not cause AIDS, but in many ways the damage from his irresponsible rantings has been done. He'd been asserting that AIDS was simply a name for a host of fatal diseases that are worsened by poor sanitation and bad nutrition. He opposed AZT and other anti-HIV drugs, which he claimed were ineffective, toxic and un-African. His flirtation with these notions is shockingly irresponsible, but don't take our word for it. "It's a national scandal," said Malegapuru Makgoba, president of South Africa's Medical Research Council.
May 21, 2000 |
In this crowded township of 500,000 people near Cape Town, an estimated 22 percent of pregnant women have the AIDS virus. But here, unlike in the rest of South Africa, where nothing is being done to keep mothers from passing the virus to their children, the women can get free doses of AZT, which can cut infection rates by half. "When my labor pains got faster and faster, I took AZT every three hours," said Nonfundo Dubula, 26, an HIV-positive woman whose daughter Aziwe was born on April 28. "I was in labor for four days.